Don’t Blindly Buy Into the Vaccine Hype — One Stock to Avoid
Vaccine stock hype is high after some companies reported major breakthroughs. But here’s one company to avoid buying into right now.
Posted by Matthew Clark | Nov 12, 2020 | Markets, Podcast
Vaccine stock hype is high after some companies reported major breakthroughs. But here’s one company to avoid buying into right now.
Posted by Matthew Clark | Nov 10, 2020 | Investing
The WisdomTree Cloud Computing Fund (Nasdaq: WCLD) is a cloud computing ETF that will soar higher as businesses continue to utilize this tech.
Posted by Matthew Clark | Nov 8, 2020 | Markets
It’s a big cannabis earnings week, and we’ll have a chance to see how the market reacts to the incredibly tight presidential election.
Posted by Matthew Clark | Nov 7, 2020 | Investing, Podcast
Tech stocks have fueled the market rally of the last few months, and we’ve found two small-cap companies with momentum to go even higher.
Posted by Matthew Clark | Nov 6, 2020 | Investing
Curaleaf Holdings and Cresco Labs are two popular cannabis stocks, but which one is the better buy right now? Watch my video to find out.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below